1-3 of 3
Israel Henig
Close
Sort by
Journal Articles

Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis

Clinical Trials & Observations
Adi Eshel, Itai Sharon, Arnon Nagler, David Bomze, Ivetta Danylesko, Joshua A. Fein, Mika Geva, Israel Henig, Avichai Shimoni, Tsila Zuckerman, Ilan Youngster, Omry Koren, Roni Shouval
Journal: Blood Advances
Blood Adv (2022) 6 (2): 568–573.
https://doi.org/10.1182/bloodadvances.2021005110
Published: 2022
Includes: Supplemental data
Journal Articles

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study

Clinical Trials & Observations
Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren-Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, Olga Nudelman, Sigal Tavor, Shay Yeganeh, Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3740–3749.
https://doi.org/10.1182/bloodadvances.2019000468
Published: 2019
Includes: Supplemental data
Journal Articles

IAPs protect host target tissues from graft-versus-host disease in mice

Tomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, Chen Liu, Cynthia Zajac, Shin-Rong Julia Wu, Yaping Sun, Hideaki Fujiwara, Hiroya Tamaki, Daniel Peltier, Mary Riwes, Israel Henig, Stuart Brabbs, Colin S. Duckett, Shaomeng Wang, Pavan Reddy
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1517–1532.
https://doi.org/10.1182/bloodadvances.2017004242
Published: 2017
Includes: Supplemental data